Anna Rozhkova
Please introduce yourself in a few sentences.
I joined Fresenius Kabi three years ago as Senior Manager Physicochemical CMC Development. In this role, I work on development and implementation of the CMC (Chemistry, Manufacturing, and Controls) analytical strategy for biosimilars and provide strategic and scientific expertise to the team. My work contributes to the development of high-quality products that remain affordable for patients.
I am biochemist by training. I completed my PhD in natural sciences at ETH Zurich, Switzerland. I have worked in biopharmaceutical companies for about 20 years, always focusing on protein analytics, innovative technologies, and development of analytical methods that meet the requirements of the biopharmaceutical environment.
What inspired you to choose a career in science?
Since childhood, I have been curious and wanted to understand why things are the way they are. At school, I found scientific disciplines much more interesting than languages or literature. That interest led me to study biochemistry, then to do a PhD, and eventually to pursue a career in biopharma.
Was there a moment or turning point that shaped your path in science?
The turning point was my first role as an analytical scientist. That position set everything in motion, and 20 years later I am still working in this field. Analytics plays an important role in ensuring that products delivered to patients consistently meet high quality standards. In biosimilar development, analytics becomes even more important because it represents a large part of the submission dossier.
What accomplishment in your role do you look back on with pride?
Among other achievements, I am proud of my contribution to the establishment of monoclonal antibody analytics at a previous company. When I joined in 2006, the first project was about to start, and I set up the initial physicochemical analytical methods. During that time, I also developed an innovative method that was published in 2009.
How do you support or encourage younger colleagues who are starting out?
I enjoy sharing knowledge and experience, because seeing colleagues grow into strong professionals is very rewarding. As a group leader, I always explained the broader context to younger team members, such as how their individual tasks connected to other project activities or to patient health. It is important and motivating to see the bigger picture and to remember that the ultimate goal is to support patients and that every activity, no matter how small, contributes to that.
What would you tell girls and young women who are considering a career in science?
Science is not about gender; it’s about your interest and passion. Follow your passion, stay curious, keep learning, and your path will unfold.